Boost Surge X Ingredients: All Seven, With Amounts

The largest of the plant items on this panel, tied with saw palmetto, nettle and wild yam at 20 mg. Sarsaparilla is a climbing vine whose root has been used in tonic drinks for centuries, and the chemistry people point to is its steroidal saponins, chiefly sarsasapogenin. What the research actually shows: Tian 2017 catalogues those saponins and what they do in laboratory models, and a 2024 Smilax review is a full review of one widely used species. Both are chemistry and pharmacology reviews. The part that matters: neither describes a controlled human trial of sarsaparilla for testosterone, vitality or male function, because there is not a meaningful one to describe. A steroidal saponin is not a steroid hormone and the human body does not convert one into the other. Traditional preparations also used grams of dried root in a decoction, not 20 mg of extract in a capsule.

The smallest botanical figure on the panel except for horny goat weed, and the one with the strongest human evidence behind the plant itself. That combination is the single most important thing on this label. What the research shows: Talbott 2013 gave 200 mg a day of a standardised water-soluble extract to moderately stressed adults for four weeks and reported lower cortisol and higher testosterone. Tambi 2012 used the same 200 mg daily dose in men with late-onset hypogonadism. a 2017 systematic review pooled the clinical work and found the quality mixed and the trials small. The gap: this label prints 10 mg. That is one twentieth of the amount used in both of those trials, and the trials used a specific standardised water extract rather than unspecified root powder. Nothing on the panel says which is in the capsule. We are not going to tell you that 10 mg does what 200 mg did.

The smallest figure on the panel. The name is folk taxonomy rather than pharmacology, and the compound the laboratories care about is icariin, a flavonoid glycoside. What the research shows: Dell'Agli 2008 tested icariin and several semi-synthetic derivatives against human phosphodiesterase-5 and found the derivatives potent. That is a test-tube finding on isolated and in some cases chemically modified molecules, not a trial of a plant powder in people. the Epimedium review is a full ethnopharmacological review of the genus and is the fairest summary available. The gap: whole Epimedium leaf is roughly one to two per cent icariin at best, so 8 mg of leaf carries a fraction of a milligram of the compound in question. No human trial has established a dose for the herb. Anyone quoting the phosphodiesterase work at you as though it applied to a capsule is overreaching.

A dwarf palm from the American southeast, and the best-studied item on this panel by a distance. It is studied for prostate symptoms rather than for vitality. What the research shows, including the unflattering part: the Cochrane review pooled the randomised evidence and concluded that saw palmetto did not improve urinary symptoms or flow measures more than placebo in men with benign prostatic hyperplasia. the CAMUS trial went further and escalated the dose to three times the usual 320 mg a day, and still found no benefit over placebo. NCCIH summarises the position for a general reader. The gap: the standard studied dose is 320 mg a day of a lipidosterolic extract. This label prints 20 mg, one sixteenth of that, of an extract whose type is not stated. The honest reading is that saw palmetto is here because buyers in this category expect to see it.

Nettle is two different supplements depending on which part of the plant is used. Nettle leaf is a mild diuretic with a long food history. Nettle root is the one studied in men, and it is the one this category usually means. The panel says only nettle extract, so which part is in the capsule is not published. What the research shows: Safarinejad 2005 ran a six-month randomised, placebo-controlled crossover trial of nettle root extract at 120 mg three times a day, 360 mg in total, and reported improved urinary symptom scores. Chrubasik 2007 is the standing review of the root literature and is more cautious about the size of the effect. The gap: 20 mg against 360 mg, with the plant part unstated. Two unknowns on one line of a panel is more than this ingredient deserves.

Wild yam is the source of diosgenin, and diosgenin is genuinely the starting material that chemists once used to manufacture steroid hormones in a laboratory. That fact is the reason wild yam appears in supplements at all, and it is routinely misread. What the research shows: a 2022 review of diosgenin reviews diosgenin's pharmacology in detail. Komesaroff 2001 is the trial worth knowing: a randomised crossover study of wild yam extract in healthy menopausal women found no effect on symptoms, blood lipids or sex hormones compared with placebo. It studied women rather than men, which limits what it says here, but it is the controlled human test that exists. The part nobody selling this will tell you: the conversion of diosgenin into a steroid hormone is an industrial chemical process. The human body does not perform it. Eating wild yam does not make hormones.

The one item on this panel that is a mineral rather than a plant, and the figure that needs reading most carefully. What the research shows: Naghii 2011 gave 10 mg of boron a day for a week to a small group of healthy men and reported a rise in free testosterone and a fall in estradiol. Pizzorno 2015 is a broad review of boron in human nutrition. The figure that should stop you: the NIH Office of Dietary Supplements publishes a Tolerable Upper Intake Level for boron of 20 mg a day for adults aged 19 and over, from all sources including food, and notes that common amounts of elemental boron in dietary supplements run from 0.15 to 6 mg. Typical dietary intake adds roughly another milligram. This label prints 20 mg. If that figure is elemental boron, one serving sits on the upper limit before you have eaten anything. If it is the weight of a boron compound such as boron citrate, the elemental amount is far smaller. Which of those it is has not been published, and we will not guess. Ask a doctor or pharmacist before taking this alongside anything else containing boron.